Summary
Confusion over similar drug names is one of the reasons for errors in the prescribing or administration of drugs. The risks of such errors could be reduced by some simple measures.
National and international agencies:
-
•
Licensing authorities should exercise more control over the naming of new proprietary formulations
-
•
Nonproprietary names should be internationalised
-
•
New proprietary names should be internationalised
-
•
Common prefixes in names should be avoided if possible.
Pharmaceutical manufacturers:
-
•
Manufacturers should play their part in ensuring that new names are carefully chosen and internationalised
-
•
Over-the-counter formulations should be given unique names
-
•
Generic formulations should be marketed under their nonproprietary names, not new proprietary names.
Doctors:
-
•
Should inform patients about the nature and risks of their therapy
-
•
Should issue printed prescriptions if possible, or use clearly-penned block capitals in handwritten prescriptions. In most cases they should use nonproprietary names when prescribing. Abbreviations of drug names should never be used.
Pharmacists:
-
•
Should discuss the nature and risks of patientsss’ therapy with them and check that they recognise the medicines they are taking
-
•
Should ask patients to hand in their old medicines containers when they fill a new prescription
-
•
In hospital, clinical pharmacists can help to check doctorss’ prescriptions and to liaise between doctors and nurses, advising on correct therapy.
Special cases:
-
•
Special care should be taken with sulphonylureas: manufacturers should produce distinctive formulations and pharmacists should keep them in a separate section in the dispensary.
Similar content being viewed by others
References
Ferner RE. Errors in prescribing and giving drugs. J Med Def Union 1992; 3: 60–3
Simonyi M, Gal J, Testa B. Signs of the times: the need for a stereochemically informative name system. Trends Pharmacol Sci 1989; 10: 349–54
McNulty H, Spurr P. Drugs which can cause problems and confusion to health care staff. Pharm J 1982; 229: 721–3
McNulty H, Spurr P. Drug names that look or sound alike. BMJ 1979; 2: 836
McNulty H, Spurr P. Drugs names which look or sound alike. Pharm J 1982; 229: 686–8
Eckert GM, Wheatley GW. Confusing drug names as a contributing factor in drug administration error. Aust J Hosp Pharm 1978; 8: 93–5
Teplitsky B. Caution: 1000 drugs whose names look alike or sound alike. Pharm Times 1978; 44: 41–3
Huminer D, Dux S, Rosenfeld JB, et al. Inadvertent sulfonyl-urea-induced hypoglycaemia. A dangerous, but preventable condition. Arch Intern Med 1989; 149: 1890–2
Hooper PL, Tello RJ, Burstein PJ, et al. Pseudoinsulinoma: the Diamox—Diabinese switch [letter], N Engl J Med 1990; 323: 488
Huseby JS, Anderson P. Confusion about drug names [letter]. N Engl J Med 1991; 325: 588
Shumak SL, Corenblum B, Steiner G. Recurrent hypoglycemia secondary to drug-dispensing error. Arch Intern Med 1991; 151: 1877–8
Rutzen AR, Weiss JS. Substitution of acetohexamide for acetazolamide. Am J Ophthalmol 1993; 116: 379–80
Fairburn RA. Drug names that look or sound alike [letter]. BMJ 1979; 2: 1073
Romer C. Drug names that look or sound alike [letter]. BMJ 1979; 2: 1073
Reddington MB. Drug names that look or sound alike [letter]. BMJ 1980; 1: 572
Whittaker RL. Confused drug names [letter]. Ann Intern Med 1980; 93: 933
Simpson P, Macaulay D. Management of gastroenteritis at home. BMJ 1981; 283: 1607
Cousins DH, Upton DR. But of course no one would do that… Hosp Pharm Pract 1994; 4: 124
Aldrich TK. Confused drug names [letter]. Ann Intern Med 1980; 93: 933–4
Anonymous. Badly written prescription leads to dispensing error. Pharm J 1977; 219: 346
Anonymous. Woman died after pharmacists’s error. Pharm J 1984; 232: 664
Kurth MC, Langston JW, Tetrud JW ’stelazine’ versus ’selegiline’: a hazard in prescription writing [letter]. N Engl J Med 1990; 323: 1776
Cohen MR. Medication error reports. Hosp Pharm 1982; 17: 357
Aronson JK. Whats’s in a brand-name? BMJ 1994; 308: 1140–1
Cousins DH, Upton DR. Watch out for drug name abbreviations. Hosp Pharm Pract 1994; 4: 28
World Health Organization. Twentieth report of the expert committee on nonproprietary names for pharmaceutical substances. Technical Report Series, 581. Geneva: WHO, 1975
Trigg RB. Current trends in the selection of nonproprietary names for medicinal substances. Pharm J 1978: 220: 181–3
Beary JF. Confusion about drug names [letter]. N Engl J Med 1991; 325: 588–9
Hashiba S, Takenaka Y, Nakadate M. Development of a database of nonproprietary names of drugs. Eisei Shikenjo Hokoku 1989; 107: 141–5
Fine SN, Eisdorfer RM, Miskovitz PF, et al. Losec or Lasix? [letter] N Engl J Med 1990; 322: 1647
McNulty H. Brand names [letter]. Pharm J 1982; 229: 432
Sandier DA, Mitchell JR, Fellows A, et al. Is an information booklet for patients leaving hospital helpful and useful? BMJ 1989; 298: 870–4
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aronson, J.K. Confusion Over Similar Drug Names. Drug-Safety 12, 155–160 (1995). https://doi.org/10.2165/00002018-199512030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199512030-00001